# KEYTRUDA QLEX
> **BLA761467** · Biologics License Application · Sponsor: MERCK SHARP DOHME · Approved 2025-09-19
## Drug
- **FDA Application Number:** BLA761467
- **Application type:** Biologics License Application
- **Brand name:** KEYTRUDA QLEX
- **Generic name:** PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH
- **Active ingredients:** PEMBROLIZUMAB; BERAHYALURONIDASE ALFA-PMPH
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** MERCK SHARP DOHME
- **Manufacturer:** Merck Sharp & Dohme LLC
- **First approval:** 2025-09-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761467)
---
*AI Analytics · CC0 1.0*